Albireo Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Albireo Pharma and buy or sell other stocks, ETFs, and their options commission-free!About ALBO
Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat.
CEOChristelle Huguet, PhD
CEOChristelle Huguet, PhD
Employees—
Employees—
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2003
Founded2003
Employees—
Employees—
ALBO Key Statistics
Market cap915.89M
Market cap915.89M
Price-Earnings ratio-6.57
Price-Earnings ratio-6.57
Dividend yield—
Dividend yield—
Average volume1.00M
Average volume1.00M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$45.23
52 Week high$45.23
52 Week low$16.02
52 Week low$16.02
Stock Snapshot
As of today, Albireo Pharma(ALBO) shares are valued at $44.15. The company's market cap stands at 915.89M, with a P/E ratio of -6.57.
On 2025-12-06, Albireo Pharma(ALBO) stock opened at —, reached a high of —, and a low of —.
The Albireo Pharma(ALBO)'s current trading volume is 0, compared to an average daily volume of 1M.
In the last year, Albireo Pharma(ALBO) shares hit a 52-week high of $45.23 and a 52-week low of $16.02.
In the last year, Albireo Pharma(ALBO) shares hit a 52-week high of $45.23 and a 52-week low of $16.02.
People also own
Based on the portfolios of people who own ALBO. This list is generated using Robinhood data, and it’s not a recommendation.